Rank 17 in the 2024 CWE Top 25 (frequency x severity of CVEs). The product exposes sensitive information to an actor that is not explicitly authorised to have access to it.
The graph holds this control, the 0 it maps to, and the evidence behind each claim, over MCP and REST.